Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL- 29.1.22 and SK-MEL-29.1.29

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2149-2157

  Wang, Zhigang ^a,e   Seliger, Barbara ^b   Mike, Norio ^a   Momburg, Frank ^c   Knuth, Alex ^d   Ferrone, Soldano ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d KRANKENHAUS NORDWEST   (Germany)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME 6; CHROMOSOME LOSS; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE DELETION; HUMAN; HUMAN CELL; INTRON; MELANOMA CELL; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; BASE SEQUENCE; GENE DELETION; GENES, MHC CLASS I; HLA-A2 ANTIGEN; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; RESTRICTION MAPPING; RNA, MESSENGER; SEQUENCE ALIGNMENT; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032523794     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Ferrone, S., and Marincola, F. M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 16: 487-494, 1995.
2. van Duinen, S. G., Ruiter, D. J., Broecker, E. B., van der Velde, E. A., Sorg, C., Welvaart, K., and Ferrone, S. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma. Cancer Res., 48: 1019-1025, 1988.
3. Rosenberg, S. A. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J. Natl. Cancer Inst., 88: 1635-1644, 1996.
4. D'Urso, C. M., Wang, Z., Cao, Y., Tatake, R., Zeff, R. A., and Ferrone, S. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J. Clin. Invest., 87: 284-292, 1991.
5. 2-microglobulin messenger RNA. J. Clin. Invest., 91: 684-692, 1993.
6. Wang, Z., Margulies, L., Hicklin, D. J., and Ferrone, S. Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression. Tissue Antigens, 47: 382-390, 1996.
7. Versteeg, R., Noordermeer, I. A., Kruse-Wolters, M., Ruiter, D. J., and Schrier, P. I. c-myc down-regulates class I HLA expression in human melanomas. EMBO J., 7: 1023-1029, 1988.
8. Marincola, F. M. P. Shamamian, R. B., Alexander, J. R., Gnarra, R. L. Turetskaya, S. A., Nedospasov, T., Simonis, B., Taubenberger, J. K., Yannelli, J., Mixon, A., Restifo, N. P., Herlyn, M., and Rosenberg, S. A. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol., 153: 1225-1237, 1994.
9. Wolfel, T., Klehmann, E., Muller, C., Schutt, K. H., Meyer-zum-Buschenfelde, K. H., and Knuth, A. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J. Exp. Med., 170: 797-810, 1989.
10. Janatipour, M., Trainor, K. J., Kutlaca, R., Bennett, G., Hay, J., Turner, D. R., and Morley, A. A. Mutations in human lymphocytes studied by an HLA selection system. Mutat. Res., 198: 221-226, 1988.
11. Turner, D. R., Grist, S. A., Janatipour, M., and Morley, A. A. Mutations in human lymphocytes commonly involve gene duplication and resemble those seen in cancer cells. Proc. Natl. Acad. Sci. USA, 85: 3189-3192, 1988.
12. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T., and Coulie, P. G. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol., 25: 340-347, 1995.
13. Restifo, N. P., Marincola, F. M., Kawakami, Y., Taubenberger, J., Yannelli, J. R., and Rosenberg, S. A. Loss of functional β 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst., 88: 100-108, 1996.
14. Natali, P. G., Nicotra, M. R., Bigotti, A., Venturo, I., Marcenaro, L., Giacomini, P., and Russo, C. Selective changes in expression of HLA class I polymorphic-determinants in human solid tumors. Proc. Natl. Acad. Sci. USA, 86: 6719-6723, 1989.
15. Kageshita, T., Wang, Z., Calorini, L., Yoshii, A., Kimura, T., Ono, T., Gattoni-Celli, S., and Ferrone, S. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res., 53: 3349-3354, 1993.
16. Slingluff, C. L., Jr., Hunt, D. F., and Engelhard, V. H. Direct analysis of tumor-associated peptide antigens. Curr. Opin. Immunol., 6: 733-740, 1994.
17. Crowley, N. J., Darrow, T. L., Quinn Allen, M. A., and Seigler, H. F. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele. J. Immunol., 146: 1692-1699, 1991.
18. Seliger, B., Hohne, A., Knuth, A., Bernhard, H., Meyer, T., Tampe, R., Momburg, F., and Huber, C. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res., 56: 1756-1760, 1996.
19. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfre, G., Milstein, C., Williams, A. F., and Ziegler, A. Production of monoclonal antibodies to group A erythrocytes, HLA and the human cell surface antigens: new tools for genetic analysis. Cell, 14: 9-20, 1978.
20. McMichael, A. J., Parham, P., Rust, N., and Brodsky, F. A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum. Immunol., 1: 121-129, 1980.
21. Russo, C., Ng, A. K., Pellegrino, M. A., and Ferrone, S. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics, 18: 23-35, 1983.
22. Stam, N. J., Spits, H., and Ploegh, H. L. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol., 137: 2299-2306, 1986.
23. Tsujisaki, M., Sakaguchi, K., Igarashi, M., Richiardi, P., Perosa, F., and Ferrone, S. Fine specificity and idiotype diversity of the murine anti-HLA-A2, A28 monoclonal antibodies CR11-351 and KS1. Transplantation, 45: 632-639, 1988.
24. Tanabe, M., Sekimata, M., Ferrone, S., and Takiguchi, M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α 3 domain. J. Immunol., 148: 3202-3209, 1992.
25. Brodsky, F. M., Bodmer, W. F., and Parham, P. Characterization of a monoclonal anti-β 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur. J. Immunol., 9: 536-545, 1979.
26. Meyer, T. H., Van Endert, P. M., Uebel, S., Ehring, B., and Tampe, R. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett., 351: 443-447, 1994.
27. Nakamuro, K., Tanagaki, N., and Pressman, D. Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000-Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules. Immunology, 29: 1119-1132, 1975.
28. Fernandez-Vina, M. A., Falco, M., Sun, Y., and Stastny, P. DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of-A28. Hum. Immunol., 33: 163-173, 1992.
29. Oh, S. H., Fleischhauer, K., and Yang, S. Y. Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. Tissue Antigens, 41: 135-142. 1993.
30. Bunce, M., and Welsh, K. I. Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens, 43: 7-17, 1994.
31. Levine, J. E., and Yang, S. Y. SSOP typing of the Tenth International Histocompatibility Workshop reference cell lines for HLA-C alleles. Tissue Antigens, 44: 174-183, 1994.
32. Geliebter, J., Zeff, R. A., Melvold, R. W., and Nathenson, S. G. Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6. Proc. Natl. Acad. Sci. USA, 83: 3371-3375, 1986.
33. Koller, B. H., Sidwell, B., DeMars, R., and Orr, H. T. Isolation of HLA locus-specific DNA probes from the 3′-untranslated region. Proc. Natl. Acad. Sci. USA, 81: 5175-5178, 1984.
34. Feinberg, A. P., and Vogelstein, B. Addendum. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 137: 266-267, 1984.
35. Vega, M. A., and Strominger, J. L. Constitutive endocytosis of HLA class I antigens requires a specific portion of the inracytoplasmic tail that shares structural features with other endocytosed molecules. Proc. Natl. Acad. Sci. USA, 86: 2688-2692, 1989.
36. Hunter, W. M., and Greenwood, F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (Lond.), 194: 495-496, 1962.
37. 2-microglobulin gene-null FO-1 melanoma cells. Cancer Res., 53: 4303-4309, 1993.
38. Yang, S. Y. A standardized method for detection of HLA-A and HLA-B alleles by one-dimensional isoelectric focusing (IEF) gel electrophoresis. In: B. Dupont, (ed.) Immunobiology of HLA, pp. 332-335. New York: Springer-Verlag, 1989.
39. Davis, L. G., Dibner, M. D., and Battey, J. F. Guanidine isothiocyanate preparation of total RNA. In: L. G. Davis, M. D. Dibner, and J. F. Battey (eds.), Basic Methods of Molecular Biology, pp. 130-135. New York: Elsevier Science Publishing Co., Inc., 1986.
40. Perbal, B. Purification of high molecular weight cellular DNA. In: B. Perbal (ed.), A Practical Guide to Molecular Cloning, pp. 324-326. New York: John Wiley & Sons, 1988.
41. Kawasaki, E. S. Sample preparation from blood, cells, and other fluids. In: M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White, (eds.), PCR Protocols: A Guide to Methods and Applications, pp. 146-152. San Diego, CA: Academic Press, Inc., 1990.
42. Loh, E. Y., Elliott, J. F., Cwirla, S., Lanier, L. L., and Davis, M. M. Polymerase chain reaction with single-sided specificity: analysis of T cell receptor delta chain. Science (Washington DC), 243: 217-220, 1989.
43. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
44. Momburg, F., Roelse, J., Hammerling, G. J., and Neefjes, J. J. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med., 179: 1613-1623, 1994.
45. Francke, U., and Pellegrino, M. A. Assignment of the major histocompatibility complex to a region of the short arm of human chromosome 6. Proc. Natl. Acad. Sci. USA, 74: 1147-1151, 1997.
46. Ochi, H., Wake, N., Rao, U., Takeuchi, J., Slocum, H. K., Rustum, Y. M., Karakousis, C., and Sandberg, A. A. Serial cytogenetic analysis of a recurrent malignant melanoma. Cancer Genet. Cytogenet., 11: 175-183, 1984.
47. Kotler, B. H., and Orr, H. T. Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level. J. Immunol., 134: 2727-2733, 1985.
48. Glickman, B. G., Fix, D. F., Yatagai, F., Burns, P. A., and Schaaper, R. M. Mechanisms of spontaneous mutagenesis: clues from mutational specificity. In: M. G. Simic, L. Grossman, and A. C. Upton, (eds.) Mechanisms of DNA Damage and Repair. Implications for Carcinogenesis and Risk Assessment, pp. 425-436. New York: Plenum Press, 1986.
49. Morley, A. A., Grist, S. A., Turner, D. R., Kutlaca, A., and Bennett, G. Molecular nature of in vivo mutations in human cells at the autosomal HLA-A locus. Cancer Res., 50: 4584-4587, 1990.
50. Browning, M. J., Krausa, P., Rowan, A., Bicknell, D. C., Bodmer, J. G., and Bodmer, W. G. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc. Natl. Acad. Sci. USA, 90: 2842-2845, 1993.
51. Imreh, M. P., Zhang, Q. J., de Campos Lima, P. O., Imreh, S., Krausa, P., Browning, M, Klein, G., and Masucci, M. G. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma. Int. J. Cancer, 62: 90-96, 1995.
52. Fountain, J. W., Bale, S. J., Housman, D. E., and Dracopoli, N. C. Genetics of melanoma. Cancer Surv., 9: 645-671, 1990.
53. 2-microglobulin. J. Immunol., 140: 2322-2329, 1988.
54. 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur. J. Immunol., 18: 801-810, 1988.
55. Neisig, A., Wubbolts, R. Zang, X., Melief, C., and Neefjes, J. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol., 156: 3196-3206, 1996.
56. Wei, M. L., and Cresswell, P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature (Lond.), 356: 443-446, 1992.
57. Seliger, B., Maeurer, M. J., and Ferrone, S. TAP off: tumors on. Immunol. Today, 18: 292-299, 1997.
58. Rivoltini, L., Barracchini, K. C., Viggiano, V., Kawakami, Y., Smith, A., Mixon, A. Restifo, N. P., Topalian, S. L., Simonis, T. B., Rosenberg, S. A., and Marincola, F. M. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res., 55: 3149-3157, 1995.